SightfileU.S. market data from official filings

Companies › CNMD

CONMED CORP COM (CNMD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000816956 · EDGAR filings · Updated 2026-07-17

CONMED CORP COM (CNMD) has reported institutional ownership of 110.1%, with 237 institutional managers holding positions valued at $1.20B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Institutional ownership
110.1%
Institutional managers
237
Reported 13F value
$1.20B
Insider activity
27 trans.
−$527.3K net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CONMED CORP COM has 237 institutional holders and institutional ownership of 110.1%.

Insider activity

Insiders reported 27 transactions (0 buys, 6 sells) across 15 reporting insiders, with a net reported value of −$527.3K.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2020-01-29 (recurring since 2020-01-29) — source filing. The authoritative details are those stated in the filing itself.

Related companies

TAYSHA GENE THERAPIES (TSHA) · U S PHYSICAL THERAPY (USPH) · BIOHAVEN LTD F (BHVN) · ORGANON & CO (OGN) · MOONLAKE IMMUNOTHERAPEUTICS (MLTX) · SAVARA INC (SVRA)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.